Retrospective review of the use of azathioprine in severe atopic dermatitis

Journal of the American Academy of Dermatology

Volumn 35, Issue 4, 1996, Pages 642-643

  Lear, John T ^a   English, John S C ^a   Jones, Peter ^b   Smith, Andrew G ^a  

^a N Staffordshire Natl Hlth S ^*  (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; BONE MARROW SUPPRESSION; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DERMATITIS; DRUG MONITORING; DRUG POTENCY; FEMALE; GASTROINTESTINAL TOXICITY; GINGIVA HYPERPLASIA; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TOXICITY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOPICAL DRUG ADMINISTRATION; TREMOR;

EID: 0030469833     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90701-X     Document Type: Article

References (9)

1. Sowden JM, Berth-Jones J, Ross JS, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991;338:137-40.
2. Younger IR, Harris DWS, Colver GB. Azathioprine in dermatology. J Am Acad Dermatol 1991;25:281-6.
3. Morrison JGL, Schulte EJ. Treatment of eczema with cyclophosphamide and azathioprine. Br J Dermatol 1978; 98:203-7.
4. Buckley DA, Baldwin P, Rogers S. Azathioprine in severe adult atopic dermatitis. Br J Dermatol 1995;133(suppl 45): 18.
5. Finlay AY, Khan GK, Luscombe DK, et al. Validation of UK sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990;123:751-6.
6. Finlay AY, Kelly SE. Psoriasis: an index of disability. Clin Exp Dermatol 1987;12:8-11.
7. Connell WR, Kamm MA, Dickson M, et al. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1995;343:1249-52.
8. Bennett JA, Christian JM. Cyclosporin induced gingival hyperplasia: case report and literature review. J Am Dent Assoc 1985;3:272-3.
9. Bunney MH, Benton EC, Barr BB, et al. The prevalence of skin disorders in renal allograft recipients receiving cyclosporin compared to those receiving azathioprine. Nephrol Dial Transplant 1990;5:379-82.